Evidence map›Paper›PMID 42891235›Full record

ArticleJTCVS techniques2026

Inflatable mediastinoscopic esophagectomy for refractory benign esophageal fistulas: An effective therapeutical methods.

Changchun Wang, Liwei Xu, Weitian Wei, Qiong He, Kelong Shao, Tianxing Ying, Weimin Mao, Qixun Chen

Abstract read
In one paragraph

Article in JTCVS techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Changchun WangDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Liwei XuDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Weitian WeiDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Qiong HeDepartment of Thoracic Tumor, Zhejiang Cancer Hospital, Hangzhou, China.
Kelong ShaoPostgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
Tianxing YingDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Weimin MaoDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Qixun ChenDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: For refractory benign esophageal fistulas unresponsive to endoscopic therapy, inflatable mediastinoscopic esophagectomy with primary reconstruction effectively addressed thoracic adhesions in 6 cases. Methods: We conducted a retrospective analysis of 6 patients with refractory benign esophageal fistulas treated, documenting etiology, preoperative treatment, surgical techniques, and postoperative results. Results: The causes were spontaneous esophageal rupture in 2 cases and iatrogenic damage in 4 cases. Disease duration ranged from 1 month to 13 years. One patient had an esophagopulmonary fistula, and 5 patients had empyema. The upper and intermediate esophagus were dissected using inflatable mediastinoscopy. The lower esophagus was dissected using laparoscopy (4 cases) or laparotomy (2 cases). All patients underwent gastric tube reconstruction with a cervical hand-sewn anastomosis. One patient experienced a cervical anastomotic leak, which was resolved with drainage within 2 weeks. The esophagopulmonary fistula resolved on the first postoperative day, and the empyema was cured in 3 to 4 weeks. Conclusions: Inflatable mediastinoscopic esophagectomy with primary gastric tube reconstruction is a safe and effective treatment for refractory benign esophageal fistulas that have failed conservative therapies.

Indexed as

benign esophageal fistulainflatable mediastinoscopic esophagectomysurgical technique

Identifiers

PMID42891235
PMCPMC13673978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.